top of page
120
OVER
YEARS
We believe uncertainty has an upside - and we can help you realise it.
The key to capturing more upside comes from our impact model.
Going beyond symptom control is the new game.
With our transparent approach, we aim to facilitate a future where essential breakthroughs are carried to the market, where we work alongside our clients to support new product launches in the pharma industry.
From board-level guidance to lobbying and regulatory advocacy, we don’t just advise - we advocate for you within the industry.
Our network multiplying effect
When you work with us, you will feel the multiplying effect of our science consulting network. It has the power to open up potential you never knew existed, helping you to market to leading drug development companies and maximise investment potential.
120
+120 years in the trenches
50
> 50 assets
10
$10b valuation
2
$2b transaction
85
85 countries
bottom of page